372 related articles for article (PubMed ID: 27128437)
1. A Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria Vaccine.
Fonseca JA; Cabrera-Mora M; Kashentseva EA; Villegas JP; Fernandez A; Van Pelt A; Dmitriev IP; Curiel DT; Moreno A
PLoS One; 2016; 11(4):e0154819. PubMed ID: 27128437
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice.
Ophorst OJ; Radosević K; Havenga MJ; Pau MG; Holterman L; Berkhout B; Goudsmit J; Tsuji M
Infect Immun; 2006 Jan; 74(1):313-20. PubMed ID: 16368986
[TBL] [Abstract][Full Text] [Related]
3. A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.
Shiratsuchi T; Rai U; Kaneko I; Zhang M; Iwanaga S; Yuda M; Tsuji M
Vaccine; 2017 Dec; 35(50):6990-7000. PubMed ID: 29089194
[TBL] [Abstract][Full Text] [Related]
4. A Recombinant Chimeric Ad5/3 Vector Expressing a Multistage Plasmodium Antigen Induces Protective Immunity in Mice Using Heterologous Prime-Boost Immunization Regimens.
Cabrera-Mora M; Fonseca JA; Singh B; Zhao C; Makarova N; Dmitriev I; Curiel DT; Blackwell J; Moreno A
J Immunol; 2016 Oct; 197(7):2748-61. PubMed ID: 27574299
[TBL] [Abstract][Full Text] [Related]
5. A prime-boost immunization regimen based on a simian adenovirus 36 vectored multi-stage malaria vaccine induces protective immunity in mice.
Fonseca JA; McCaffery JN; Kashentseva E; Singh B; Dmitriev IP; Curiel DT; Moreno A
Vaccine; 2017 May; 35(24):3239-3248. PubMed ID: 28483199
[TBL] [Abstract][Full Text] [Related]
6. Recombinant viral-vectored vaccines expressing Plasmodium chabaudi AS apical membrane antigen 1: mechanisms of vaccine-induced blood-stage protection.
Biswas S; Spencer AJ; Forbes EK; Gilbert SC; Holder AA; Hill AV; Draper SJ
J Immunol; 2012 May; 188(10):5041-53. PubMed ID: 22504652
[TBL] [Abstract][Full Text] [Related]
7. Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
Hutchings CL; Birkett AJ; Moore AC; Hill AV
Infect Immun; 2007 Dec; 75(12):5819-26. PubMed ID: 17908809
[TBL] [Abstract][Full Text] [Related]
8. Actively induced antigen-specific CD8+ T cells by epitope-bearing parasite pre-infection but not prime/boost virus vector vaccination could ameliorate the course of Plasmodium yoelii blood-stage infection.
Ono T; Yamaguchi Y; Oguma T; Takayama E; Takashima Y; Tadakuma T; Miyahira Y
Vaccine; 2012 Sep; 30(44):6270-8. PubMed ID: 22902783
[TBL] [Abstract][Full Text] [Related]
9. Genetic linkage of autologous T cell epitopes in a chimeric recombinant construct improves anti-parasite and anti-disease protective effect of a malaria vaccine candidate.
Singh B; Cabrera-Mora M; Jiang J; Galinski M; Moreno A
Vaccine; 2010 Mar; 28(14):2580-92. PubMed ID: 20097151
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of the murine IgGκ signal peptide increases the cellular immunogenicity of a simian adenoviral vectored Plasmodium vivax multistage vaccine.
Fonseca JA; McCaffery JN; Caceres J; Kashentseva E; Singh B; Dmitriev IP; Curiel DT; Moreno A
Vaccine; 2018 May; 36(20):2799-2808. PubMed ID: 29657070
[TBL] [Abstract][Full Text] [Related]
11. Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium yoelii.
González-Aseguinolaza G; Nakaya Y; Molano A; Dy E; Esteban M; Rodríguez D; Rodríguez JR; Palese P; García-Sastre A; Nussenzweig RS
J Virol; 2003 Nov; 77(21):11859-66. PubMed ID: 14557672
[TBL] [Abstract][Full Text] [Related]
12. Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses.
Bruder JT; Semenova E; Chen P; Limbach K; Patterson NB; Stefaniak ME; Konovalova S; Thomas C; Hamilton M; King CR; Richie TL; Doolan DL
PLoS One; 2012; 7(4):e33920. PubMed ID: 22496772
[TBL] [Abstract][Full Text] [Related]
13. Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine.
Chawla B; Mahajan B; Oakley M; Majam VF; Belmonte A; Sedegah M; Shimp RL; Kaslow DC; Kumar S
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31308085
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
15. The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert.
Radosevic K; Rodriguez A; Lemckert AA; van der Meer M; Gillissen G; Warnar C; von Eyben R; Pau MG; Goudsmit J
Clin Vaccine Immunol; 2010 Nov; 17(11):1687-94. PubMed ID: 20826614
[TBL] [Abstract][Full Text] [Related]
16. Chimeric epitopes delivered by polymeric synthetic linear peptides induce protective immunity to malaria.
Caro-Aguilar I; Lapp S; Pohl J; Galinski MR; Moreno A
Microbes Infect; 2005 Oct; 7(13):1324-37. PubMed ID: 16253535
[TBL] [Abstract][Full Text] [Related]
17. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
[TBL] [Abstract][Full Text] [Related]
18. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
Hoffman SL; Doolan DL
Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8
Pattinson DJ; Apte SH; Wibowo N; Rivera-Hernandez T; Groves PL; Middelberg APJ; Doolan DL
Front Immunol; 2020; 11():564627. PubMed ID: 33133076
[TBL] [Abstract][Full Text] [Related]
20. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]